Literature DB >> 21807025

Allosteric modulation of caspases.

Hans-Georg Häcker1, Mihiret Tekeste Sisay, Michael Gütschow.   

Abstract

Caspases are proteolytic enzymes mainly involved in the induction and execution phases of apoptosis. This type of programmed cell death is an essential regulatory process required to maintain the integrity and homeostasis of multicellular organisms. Inappropriate apoptosis is attributed a key role in many human diseases, including neurodegenerative disorders, ischemic damage, autoimmune diseases and cancer. Allosteric modulation of the function of a protein occurs when the regulatory trigger, such as the binding of a small effector or inhibitor molecule, takes place some distance from the protein's active site. In recent years, several caspases have been identified that possess allosteric sites and binding of small molecule to these sites resulted in the modulation of enzyme activities. Regulation of caspase activity by small molecule allosteric modulators is believed to be of great therapeutic importance. In this review we give brief highlights on recent developments in identifying and characterizing natural and synthetic allosteric inhibitors as well as activators of caspases and discuss their potential in drug discovery and protein engineering.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21807025     DOI: 10.1016/j.pharmthera.2011.07.003

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  9 in total

Review 1.  Covalent Inhibition in Drug Discovery.

Authors:  Avick Kumar Ghosh; Indranil Samanta; Anushree Mondal; Wenshe Ray Liu
Journal:  ChemMedChem       Date:  2019-03-26       Impact factor: 3.466

Review 2.  Drugs for allosteric sites on receptors.

Authors:  Cody J Wenthur; Patrick R Gentry; Thomas P Mathews; Craig W Lindsley
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013-10-02       Impact factor: 13.820

3.  Hyperbaric oxygen therapy reduces apoptosis after spinal cord injury in rats.

Authors:  Ying Long; Fang Liang; Chunjin Gao; Zhuo Li; Jing Yang
Journal:  Int J Clin Exp Med       Date:  2014-11-15

4.  In Vivo Evaluation of Radiofluorinated Caspase-3/7 Inhibitors as Radiotracers for Apoptosis Imaging and Comparison with [18F]ML-10 in a Stroke Model in the Rat.

Authors:  Marie Médoc; Martine Dhilly; Lidia Matesic; Jérôme Toutain; Anwen M Krause-Heuer; Jérôme Delamare; Benjamin H Fraser; Omar Touzani; Louisa Barré; Ivan Greguric; Franck Sobrio
Journal:  Mol Imaging Biol       Date:  2016-02       Impact factor: 3.488

5.  (E)-N'-Arylidene-2-(4-oxoquinazolin-4(3H)-yl) acetohydrazides: Synthesis and evaluation of antitumor cytotoxicity and caspase activation activity.

Authors:  Le Cong Huan; Cao Viet Phuong; Le Cong Truc; Vo Nguyen Thanh; Hai Pham-The; Le-Thi-Thu Huong; Nguyen Thi Thuan; Eun Jae Park; A Young Ji; Jong Soon Kang; Sang-Bae Han; Phuong-Thao Tran; Nguyen-Hai Nam
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

Review 6.  Coumarin as a structural component of substrates and probes for serine and cysteine proteases.

Authors:  Julian Breidenbach; Ulrike Bartz; Michael Gütschow
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-05-13       Impact factor: 3.036

7.  Microfluidic deep mutational scanning of the human executioner caspases reveals differences in structure and regulation.

Authors:  Hridindu Roychowdhury; Philip A Romero
Journal:  Cell Death Discov       Date:  2022-01-10

Review 8.  A long way to go: caspase inhibitors in clinical use.

Authors:  Shanel Dhani; Yun Zhao; Boris Zhivotovsky
Journal:  Cell Death Dis       Date:  2021-10-15       Impact factor: 8.469

9.  Non-Apoptotic Caspase Activity Preferentially Targets a Novel Consensus Sequence Associated With Cytoskeletal Proteins in the Developing Auditory Brainstem.

Authors:  Forrest Weghorst; Yeva Mirzakhanyan; Kiersten L Hernandez; Paul D Gershon; Karina S Cramer
Journal:  Front Cell Dev Biol       Date:  2022-03-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.